LoginGet started
Picture of Lasa Supergenerics logo

LASA — Lasa Supergenerics Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Lasa Supergenerics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

C2019
March 31st
2020
March 31st
2021
March 31st
C2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,6961,6732,0241,3711,296
Cost of Revenue
Gross Profit416726900400164
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,7781,5451,7101,4271,676
Operating Profit-82128314-55.6-380
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-16147.4295-61.4-423
Provision for Income Taxes
Net Income After Taxes-12036.3228-53.3-386
Net Income Before Extraordinary Items
Net Income-12036.3228-53.3-386
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-12036.3228-53.3-386
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-5.261.45.6-0.056-5.22
Dividends per Share